Correlation Between Vytrus Biotech and Arteche Lantegi

Can any of the company-specific risk be diversified away by investing in both Vytrus Biotech and Arteche Lantegi at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vytrus Biotech and Arteche Lantegi into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vytrus Biotech SA and Arteche Lantegi Elkartea, you can compare the effects of market volatilities on Vytrus Biotech and Arteche Lantegi and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vytrus Biotech with a short position of Arteche Lantegi. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vytrus Biotech and Arteche Lantegi.

Diversification Opportunities for Vytrus Biotech and Arteche Lantegi

-0.19

Correlation Coefficient

Vytrus Biotech  Arteche Lantegi

Good diversification

The 3 months correlation between Vytrus and Arteche is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Vytrus Biotech SA and Arteche Lantegi Elkartea in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arteche Lantegi Elkartea and Vytrus Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vytrus Biotech SA are associated (or correlated) with Arteche Lantegi. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arteche Lantegi Elkartea has no effect on the direction of Vytrus Biotech i.e., Vytrus Biotech and Arteche Lantegi go up and down completely randomly.

Pair Corralation between Vytrus Biotech and Arteche Lantegi

Assuming the 90 days trading horizon Vytrus Biotech SA is expected to generate 0.59 times more return on investment than Arteche Lantegi. However, Vytrus Biotech SA is 1.71 times less risky than Arteche Lantegi. It trades about 0.3 of its potential returns per unit of risk. Arteche Lantegi Elkartea is currently generating about 0.03 per unit of risk. If you would invest  216.00  in Vytrus Biotech SA on December 2, 2024 and sell it today you would earn a total of  54.00  from holding Vytrus Biotech SA or generate 25.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Vytrus Biotech SA  vs.  Arteche Lantegi Elkartea

Vytrus Biotech SA

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Vytrus Biotech SA are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, Vytrus Biotech exhibited solid returns over the last few months and may actually be approaching a breakup point.

Arteche Lantegi Elkartea

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Arteche Lantegi Elkartea are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Arteche Lantegi exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Vytrus Biotech and Arteche Lantegi

The main advantage of trading using opposite Vytrus Biotech and Arteche Lantegi positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vytrus Biotech position performs unexpectedly, Arteche Lantegi can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arteche Lantegi will offset losses from the drop in Arteche Lantegi's long position.

The idea behind Vytrus Biotech SA and Arteche Lantegi Elkartea pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.